Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US Medicare Cost For Part D Redesign Could Far Exceed Earlier Projections, CBO Says
Oct 03 2024
•
By
Cathy Kelly
CBO's Score Is An Attention Getter But $10bn Range In Forecast Underscores Uncertainty • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Market Access
More from Pink Sheet